Abstract

BackgroundWhile most people living with HIV who are incarcerated in United States receive appropriate HIV care while they are in prison, interruptions in antiretroviral therapy and virologic failure are extremely common after they are released. The purpose of this study was to describe whether and how HIV stigma influences continuity of care for people living with HIV while they transition from prison to community settings.MethodsWe conducted semi-structured, telephone-based interviews with 32 adults who received HIV care while residing in a Wisconsin state prison, followed by a second interview 6 months after they returned to their home community. Interview transcripts were analyzed by an interdisciplinary research team using conventional content analysis. We identified themes based on commonly-reported experiences that were characterized as internalized stigma, perceived stigma, vicarious stigma, or enacted stigma.ResultsAll four forms of HIV stigma appeared to negatively influence participants’ engagement in community-based HIV care. Mechanisms described by participants included care avoidance due to concerns about HIV status disclosure and symptoms of depression and anxiety caused by internalized stigma. Supportive social relationships with clinic staff, professional case managers and supportive peers appeared to mitigate the impact of HIV stigma by increasing motivation for treatment adherence.ConclusionsHIV stigma is manifest in several different forms by people living with HIV who were recently incarcerated, and are perceived by patients to negatively influence their desire and ability to engage in HIV care. By being cognizant of the pervasive influence of HIV stigma on the lives of criminal justice involved adults, HIV care providers and clinical support staff can ameliorate important barriers to optimal HIV care for a vulnerable group of patients.

Highlights

  • While most people living with human immunodeficiency virus (HIV) who are incarcerated in United States receive appropriate HIV care while they are in prison, interruptions in antiretroviral therapy and virologic failure are extremely common after they are released

  • Participants Beginning in October 2013, a research assistant screened all patients referred for HIV care by the Wisconsin Department of Corrections (DOC) for eligibility in the study

  • I just need her to educate me. (26 year-old man, pre-release interview). In this analysis of semi-structured interviews among a cohort of people living with HIV who are released from prison, we found evidence supporting a pervasive impact of HIV stigma, which influences the way people seek and receive care during the re-entry period

Read more

Summary

Introduction

While most people living with HIV who are incarcerated in United States receive appropriate HIV care while they are in prison, interruptions in antiretroviral therapy and virologic failure are extremely common after they are released. Antiretroviral therapy is effectively administered in most prison settings, and those receiving HIV care in prison tend to have good treatment outcomes (Meyer et al, 2014a; Springer, Friedland, Doros, Pesanti, & Altice, 2007). Engagement in HIV care, including attendance at scheduled clinic appointments and adherence to antiretroviral therapy tends to be inconsistent during the re-entry period, leading to frequent lapses in treatment and virologic failure (Baillargeon et al, 2009; Meyer et al, 2014a; Springer et al, 2004)

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call